| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |